Two recently introduced patent reform bills target narrow though important slices of the intellectual property field. Perhaps for that reason, they are more likely than their ambitious counterparts to become law.
Patent protections are vital for the biotech industry, and sacrificing intellectual property protections will not affect drug prices in the way that some have predicted.
The issuance of the ten millionth patent by the US Patent and Trademark Office offers a good opportunity to reflect on the greatness of the American patent system.
The Supreme Court is on the right track to modernize patent law for a smartphone world, but lower courts aren’t getting the message.
The US has a strong case and compelling incentives to confront China’s entrenched protectionist state capitalism in trade negotiations.
Despite speculation late last year that the days of Patent Office trials might be numbered, the Supreme Court has ensured the continuation of a practice that has roiled the patent world over the last five years.
Before Washington breaks up Facebook, heavily regulates it, or nationalizes it, maybe it would be wise to make sure there’s actually a serious problem demanding government intervention.
What are the implications of a key ruling last month in a landmark copyright case that pitted two software heavyweights against each other?
As the US and China move toward confrontation across a wide number of economic and strategic fronts, Chinese cyberespionage is on the rise again.
It often seems as if everything is political and sides must always be chosen. And that is why the risk of Washington eventually regulating Big Tech is higher than it might appear right now.